Research Grants show all

NIH6

Publications show all

Mirna Therapeutics has published 18 articles.

Patents show all

59Applications17Issued

Clinical Trials show all

1Phase 11Phase 1/Phase 2

SEC Filings show all

8-K2110-Q6D310-K2S-11

SEC Form D Funding Events

DateOfferedSoldType
2015-05-01$45,000,000$41,789,527Equity
2012-11-02$34,499,990$17,249,995Equity
2011-08-23$1,500,000$1,500,000Equity

Key Executives

  • Paul Lammers
    Executive Officer, Director
  • Matthew M Winkler
    Director
  • Christopher D Earl
    Director
  • Evan S Melrose
    Director
  • Corey S Goodman
    Director
  • Lynne Hohlfeld
    Executive Officer
  • Ana C Ward
    Executive Officer
  • Michael Powell
    Director
  • Elaine V Jones
    Director
  • Edward Mathers
    Director
  • Corey Goodman
    Director
  • Ana Ward
    Executive Officer
  • Jon Irvin
    Executive Officer
  • Sinil Kim
    Executive Officer
  • Casi DeYoung
    Executive Officer
  • Matthew Winkler
    Director
  • Clay Siegall
    Director
  • Larry Alleva
    Director
  • Elaine Jones
    Director
  • Ed Mathers
    Director